When do I go to meet with FDA?
Ophthalmic Product Development Insights
Sorting Out the Stats from the Jaks
The 20th anniversary of a landmark scientific discovery provides
an opportunity to look into the future of ocular therapies.
Begin with the End in Mind
Ophthalmic Product Development Insights
Pre-clinical models
Ora’s pre-clinical group is busy developing a number of animal models of ocular disease to use in early stages of the development and candidate drug screening process.
The Antimicrobial Evolution
With several new therapies in the pipeline, practitioners may soon have a
new arsenal of drugs to better treat ocular infections.
Staying Local with Blepharitis Treatment
Ways to diagnose and categorize the disease, and thoughts on the best way to treat it when it occurs.
Of Biomes, Biofilm and The Ocular Surface
Knowing how bacteria grow and communicate may hold the
key to future treatments for ophthalmic infections.
Ora in India
Ocular therapeutics is a global business so it’s no surprise that current Ora projects include studies around the world.
Farewell, Fort Lauderdale
‘Translational research: Seeing the possibilities’ focus of finale in Florida host city
ARVO 2012 Gives Florida Our Best
Highlights from the final Fort Lauderdale meeting of the
Association for Research in Vision and Ophthalmology.